AnandRathi

Gland Pharma Ltd Fundamental Analysis

Last Updated Date: 18 Sept 2026
₹2,961.90
+51.25 (+1.76%)

Gland Pharma Ltd (Gland Pharma) fundamental analysis breaks down the key financial metrics of the mid-cap Pharmaceuticals company, which carries a market capitalisation of ₹48,875 crore.

Gland Pharma Ltd Overview

Market cap₹48,875 Crs
Volume1,62,074
Prev. Close₹2,910.65
Year range₹1,575.00 - ₹3,041.95
ISININE068V01023

Gland Pharma Ltd Fundamentals

ROCE(TTM)16.34%
P/E Ratio (TTM)35.04
P/B Ratio4.52
Debt to Equity0.00
ROE12.02%
EPS (TTM)85.60
Dividend Yield0.67%
Book Value655.11
Profit Margin29.43%
Operating Margin33.36%

Gland Pharma Ltd Historical Performance

1 Month Return3.60%
6 Month Return78.06%
3 Year Return74.61%
3 Month Return34.57%
1 Year Return46.82%
5 Year Return-23.28%

Gland Pharma Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research